- Previous Close
41.16 - Open
41.71 - Bid 41.00 x --
- Ask 41.04 x --
- Day's Range
40.52 - 41.95 - 52 Week Range
28.50 - 61.66 - Volume
1,555,981 - Avg. Volume
1,333,272 - Market Cap (intraday)
3.726B - Beta (5Y Monthly) 0.52
- PE Ratio (TTM)
45.56 - EPS (TTM)
0.90 - Earnings Date --
- Forward Dividend & Yield 0.90 (2.19%)
- Ex-Dividend Date Jun 26, 2024
- 1y Target Est
--
Bide Pharmatech Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. The company's products are used in life sciences, organic chemistry, materials science, analytical chemistry, and other applications. The company was incorporated in 2007 and is headquartered in Shanghai, China.
www.bidepharmatech.com846
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 688073.SS
View MorePerformance Overview: 688073.SS
Trailing total returns as of 4/14/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688073.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688073.SS
View MoreValuation Measures
Market Cap
3.74B
Enterprise Value
2.67B
Trailing P/E
45.73
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.35
Price/Book (mrq)
1.87
Enterprise Value/Revenue
2.43
Enterprise Value/EBITDA
26.30
Financial Highlights
Profitability and Income Statement
Profit Margin
7.29%
Return on Assets (ttm)
2.42%
Return on Equity (ttm)
3.90%
Revenue (ttm)
1.1B
Net Income Avi to Common (ttm)
80.03M
Diluted EPS (ttm)
0.90
Balance Sheet and Cash Flow
Total Cash (mrq)
1.17B
Total Debt/Equity (mrq)
4.47%
Levered Free Cash Flow (ttm)
-7.25M